Director/PDMR Shareholding

RNS Number : 2773E

GlaxoSmithKline PLC

04 April 2011

 



 Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

I give below details of changes in the directors' interests in the Ordinary shares and American Depository Shares (ADSs) of GlaxoSmithKline plc.

On 31 March 2011, the Company's Non-Executive Directors were provisionally allocated awards over Ordinary shares at a price of £11.90 per Ordinary share and $38.34 per ADS under the share allocation arrangements for Non-Executive Directors for the period of service from 1 January 2011 to 31 March 2011:

Non Executive Director	Ordinary Shares	American Depository Shares (ADSs)
Sir Christopher Gent	2836.13
Prof. Sir Roy Anderson	866.60
Dr Stephanie Burns		540.82
Mr Lawrence Culp		1081.63
Sir Crispin Davis	3256.30
Sir Deryck Maughan		772.59
Mr James Murdoch	2836.13
Dr Daniel Podolsky		1043.00
Mr Tom de Swaan	1129.20
Sir Robert Wilson	866.60

The Company and the Non-Executive Directors were informed of these allocations on 1 April 2011.

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

V A Whyte

Company Secretary

4 April 2011

 

END

 

 

RDSQZLFBFZFBBBF